Pharmaceutical Executive

Pharmaceutical Executive: June 2026
Volume: 46
Issue: 5

Pharmaceutical Executive: May 2026
Volume: 46
Issue: 4

Pharmaceutical Executive: April 2026
Volume: 46
Issue: 3

Pharmaceutical Executive: March 2026
Volume: 46
Issue: 2

Pharmaceutical Executive: February 2026
Volume: 46
Issue: 1

Pharmaceutical Executive: December 2025
Volume: 45
Issue: 9

Pharmaceutical Executive: October 2025
Volume: 45
Issue: 8

Pharmaceutical Executive: September 2025
Volume: 45
Issue: 7

Pharmaceutical Executive: August 2025
Volume: 45
Issue: 6

Pharmaceutical Executive: June 2025
Volume: 45
Issue: 5

Pharmaceutical Executive: May 2025
Volume: 45
Issue: 4

Pharmaceutical Executive: April 2025
Volume: 45
Issue: 3

Pharmaceutical Executive: March 2025
Volume: 45
Issue: 2

Pharmaceutical Executive: February 2025
Volume: 45
Issue: 1

Pharmaceutical Executive: December 2024
Volume: 44
Issue: 12

Pharmaceutical Executive: November 2024
Volume: 44
Issue: 11

Pharmaceutical Executive: October 2024
Volume: 44
Issue: 10

Pharmaceutical Executive: September 2024
Volume: 44
Issue: 9

Pharmaceutical Executive: July/August 2024
Volume: 44
Issue: 7/8

Pharmaceutical Executive: June 2024
Volume: 44
Issue: 6

Pharmaceutical Executive: May 2024
Volume: 44
Issue: 5

Pharmaceutical Executive: April 2024
Volume: 44
Issue: 4

Pharmaceutical Executive: March 2024
Volume: 44
Issue: 3

Pharmaceutical Executive: February 2024
Volume: 44
Issue: 1

Pharmaceutical Executive: December 2023
Volume: 43
Issue: 12

Pharmaceutical Executive: November 2023
Volume: 43
Issue: 11

Pharmaceutical Executive: October 2023
Volume: 43
Issue: 10

Pharmaceutical Executive: September 2023
Volume: 43
Issue: 9

Pharmaceutical Executive: August 2023
Volume: 43
Issue: 8

Pharmaceutical Executive: July 2023
Volume: 43
Issue: 7
Advertisement
Advertisement
Trending on PharmExec
1
FDA Pannel Votes to Loosen Restrictions for Four Peptides
2
Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides
3
Healthcare on the Ballot: The 2026 Midterm Elections
4
The Business Case for Employer-Based GLP-1 Coverage
5
